Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | HER2 sensitized T-cells |
Synonyms | |
Therapy Description |
HER2 sensitized T-cells are autologous T-cells that have been sensitized to HER2 antigen, potentially resulting in increased immune response against HER2-expressing tumor cells upon transplantation (PMID: 24162107, PMID: 20068073). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
HER2 sensitized T-cells | HER2 (ERBB2) Antibody 76 | HER2 sensitized T-cells are autologous T-cells that have been sensitized to HER2 antigen, potentially resulting in increased immune response against HER2-expressing tumor cells upon transplantation (PMID: 24162107, PMID: 20068073). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT02442297 | Phase I | HER2 sensitized T-cells | T Cells Expressing HER2-specific Chimeric Antigen Receptors(CAR) for Patients With HER2-Positive CNS Tumors (iCAR) | Active, not recruiting | USA | 0 |
NCT00902044 | Phase I | Fludarabine Cyclophosphamide HER2 sensitized T-cells | Her2 Chimeric Antigen Receptor Expressing T Cells in Advanced Sarcoma | Active, not recruiting | USA | 0 |